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Glomeruloscierosis in reflux nephropathy
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Case presentation
A 32-year-old man was admitted to the Beth Israel Hospital for
evaluation of heavy proteinuria. At age 3 years the patient was admitted
to another hospital with acute urinary retention. A diverticulum of the
urinary bladder, locatedjust above the left ureteral orifice, was excised.
Postoperatively he developed a pelvic abscess that was treated success-
fully by drainage and antibiotic therapy. Three months after surgery the
child had no urinary tract symptoms, but a cystogram showed bilateral
reflux that was worse on the left. Three urinalyses in the first year after
surgery showed occasional white blood cells and a trace of protein. In
his growing years he had recurrent episodes of tonsillitis. Although he
occasionally had an aching pain localized in his left flank, he had no
signs or symptoms of urinary tract infection. At age 18 years, he was
found to have proteinuria during routine evaluation for military service.
An intravenous pyelogram performed at that time was said to be
abnormal, but no other studies were done. Six months prior to
admission, he was found to have a slightly elevated blood pressure (140/
90 mm Hg), and the 24-hour urine protein excretion was 2.8 g.
On admission to the hospital he complained only of occasional left
flank pain. He denied heavy analgesic intake, skin infections, or gross
hematuria. There was no family history of renal disease. The blood
pressure was 135/85 mm Hg; pulse, 72; and weight, 198 lbs. The ears
were noted to be large and slightly misshaped. Funduscopic examina-
tion showed minimal arterial narrowing, sharp discs, and no hemor-
rhages or exudates. The lungs and heart were normal and no hepato-
splenomegaly was evident. There was no costovertebral tenderness;
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penis, testes, and urethral meatus were normal. The prostate was of
normal size.
The BUN was 14 mg/dl; creatinine, 1.3 mg/dl (creatinine clearance,
113 mI/mm); blood chemistries were normal; the blood glucose was 93
mg/dl; and the complement profile was normal. Serum protein was 7.5
gIdI with 4.3 g/dl albumin. Urinalysis showed a pH of 5; a specific
gravity of 1.015; 4+ protein, no cells, and no bacteria. Urine culture
was sterile. The 24-hour urine protein excretion was 2.4 g.
Chest x-ray showed borderline cardiomegaly with clear lungs. An
intravenous pyelogram revealed bilateral coarse scarring with caliecta-
sis. The right kidney was smaller than the left. There was moderate
ureterectasia extending down to the ureterovesical junction. A voiding
cystourethrogram revealed a large-capacity bladder; the patient had no
urge to void after almost 500 ml of contrast material was instilled.
Bilateral reflux was greater and persistent on the left and was intermit-
tent on the right. The left ureter was dilated and tortuous. A left
ureterocele and right bladder diverticulum were visualized.
A biopsy of the left kidney showed focal scarring with interstitial
fibrosis and chronic inflammation, tubular atrophy, and dilation. Of 12
glomeruli, 4 were totally sclerosed, 4 showed segmental sclerosis, and 4
had mesangial thickening with some periglomerular fibrosis. Immuno-
fluorescent studies revealed 2+ to 3+ focal, mesangial, and peripheral
capillary loop deposition of 1gM and C3, 1 + deposition of IgG, and no
IgA. Electron microscopy disclosed extensive loss of epithelial cell foot
processes and occasional poorly defined mesangial electron-dense
deposits.
Bilateral ureteral reimplantation was performed by the Glenn-Ander-
son advancement technique. The urinary diverticulum was excised. A
cystogram done 2 months postoperatively showed no reflux. Five
months after surgery the patient was asymptomatic except for lower
bilateral flank tenderness on palpation. Blood pressure was 130/80 mm
Hg; serum creatinine was 1.3 mg/dl, the urine culture was sterile, and
the 24-hr urine protein excretion was 3.2 g. Thirteen months after
surgery his renal function remained normal but proteinuria persisted
(2.5 g/24 hours).
Discussion
DR. RAMZI S. COTRAN (F. B. Mallory Professor of Patholo-
gy, Harvard Medical School, and Chairman, Department of
Pathology, Brigham and Women's Hospital, Boston, Mass.):
This patient illustrates the recently discovered association
between glomerular proteinuria and chronic tubulointerstitial
disease, particularly reflux nephropathy and chronic pyelone-
phritis. At age 32, he manifested significant asymptomatic
proteinuria and was found to have bilateral vesicoureteral
reflux (VUR). In addition, he had coarse renal scarring and
calyceal deformity, both of which are typical of the lesions of
chronic "atrophic" pyelonephritis.
Renal scarring and VUR
Although the details of the patient's clinical history as a
young child are not available, we can assume from what we
know of the natural history of reflux nephropathy [1—3] that the
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patient's major scar formation occurred in childhood, probably
around the time that the bladder diverticulum was excised.
Paraureteral diverticula are known to be associated with VUR
[4], and a cystogram performed in this patient 3 months after
operation showed bilateral VUR. No information is available
regarding the presence of renal scars at that time, but in
children with VUR who develop renal scars, scarring is com-
monly evident at the initial radiologic investigation, which is
usually performed because of concomitant urinary tract infec-
tion [3, 5]. For example, Rolleston, Shannon, and Utley found
that 29 of 49 children with gross VUR in infancy already had
scarred kidneys by the time they reached 12 months of age [1],
and Bailey noted that 10 infants with urinary tract infection and
VUR already had evidence of renal scarring at ages less than 7
weeks [2]. In the few instances in which scars developed in
previously normal kidneys, the scarring occurred mainly before
the age of 5 years and almost invariably when urinary tract
infection also was present [5]. It must be emphasized, however,
that in many children with VUR, scarring never develops, In
fact, long-term follow-up discloses that VUR disappears either
spontaneously or with antibacterial therapy in up to 80% of
instances [3]. Severe reflux and refiux associated with scarring
are the least likely to disappear, however, accounting for the
high frequency of scarring in adults with VUR (94%) [6].
What determines this sequence of events in refiux nephrop-
athy? Hodson and associates have produced a model of surgi-
cally induced VUR in piglets [7]; using this model, Ransley and
Risdon found that three conditions are required for scarring to
occur: (1) bacterial infection, (2) vesicoureteral reflux; and (3)
intrarenal refiux [8]. These investigators observed that intrare-
nal reflux in the multipapillary kidneys of young pigs occurred
only in renal papillae that had particular morphologic character-
istics [9, 10]. In contrast to the usual conical nonrefluxing
papillae, in which the papillary ducts opened onto a convex
surface via slit-like orifices, potentially refluxing papillae were
larger, had concave rather than convex tips, and contained
papillary ducts that opened into the calyx with gaping orifices.
Concave, potentially refluxing papillae are present in normal
pigs, mostly in the upper and lower poles. More importantly,
these investigators detected similar concave papillae in the
kidneys of infants and children dying of nonrenal causes. The
authors found that two-thirds of all human kidneys contain at
least one potentially refluxing papilla, and that in one-fifth of all
human kidneys, 30% or more of papillae are concave. On the
basis of these findings, Ransley and Risdon proposed the "big-
bang" hypothesis to account for early damage in reflux
nephropathy [11]: in the presence of gross VUR, the first few
episodes of clinical or subclinical urinary tract infection affect
the concave, potentially refluxing papillae, leaving nonrefluxing
structures intact. The normal kidney parenchyma, drained by
the nonrefluxing papillae, resists damage from both infection
and VUR. It is possible that when infection occurs, the mor-
phology of some apparently nonrefluxing papillae may be
modified and thus permit intrarenal refiux and new scar forma-
tion in these previously unaffected areas, but this occurrence is
thought to be unusual. This proposed mechanism could explain
how renal scarring proceeded in this patient despite an absence
of signs or symptoms of infection after the initial episode at age
3. This long, silent history prior to diagnosis is not unusual in
refiux nephropathy first detected in adults [6].
Proteinuria and glomeruloscierosis
Clinicopathologic associations
Following an asymptomatic childhood and young adulthood,
the discovery of proteinuria was sufficient to exclude this
patient from military service at age 18. An intravenous pyelo-
gram performed at that time was said to be abnormal. By age
32, the patient had mild hypertension and significant protein-
uria; radiographic studies showed reflux nephropathy with
persistent bilateral VUR. Although the creatinine clearance was
normal, a renal biopsy revealed significant glomerular and
interstitial damage. There was segmental and focal glomerulo-
sclerosis, with total sclerosis of at least one-third of the
glomeruli.
Although one can argue that the glomerulosclerosis and the
reflux nephropathy were coincidental, recent studies suggest a
significant and prognostically important association between
the two conditions. Glomerular alterations including ischemic
changes, glomerular obsolescence, proliferation, and exudation
have long been known to occur in the kidneys of patients with
chronic pyelonephritis and have been ascribed either to associ-
ated hypertension or uremia (sometimes called an "alterative"
glomerulitis) [12—14]. In addition, earlier studies had reported
heavy proteinuria in patients with chronic pyelonephritis, but in
some instances the proteinuria was present without histologic
confirmation of glomerular lesions; in other instances criteria
for the diagnosis of chronic pyelonephritis were equivocal [15].
In 1973, Zimmerman, Uehling, and Burkholder described
focal sclerosing glomerulopathy and proteinuria (in excess of
1.5 glday) in 8 patients with renal failure and VUR [16].
Kincaid-Smith, however, was the first to draw attention to the
association of chronic pyelonephritic scarring with proteinuria
and glomerulosclerosis [17—19]. She noted that protein excre-
tions greater than 0.2 g/day were present in 19 of 55 adults with
refiux nephropathy, and that proteinuria was the best guide to
prognosis. Thus, all but one of 11 patients whose renal function
subsequently declined had significant proteinuria (mean, 2.36
g/day), whereas all patients whose serum creatinine levels
remained stable had either no proteinuria or less than 1 g in 24
hours [19]. When renal tissue was obtained from patients with
protein excretions exceeding 0.2 g!day, 78% of the specimens
showed focal and segmental hyalinosis and sclerosis [18]. These
lesions were universal in patients with a serum creatinine over
2.5 mg!dl [17].
Several other studies subsequently reported focal glomeru-
losclerosis in association with proteinuria in reflux nephropathy
[15, 20—22]. Bhathena et al found focal glomerulosclerosis in all
23 patients who had received renal transplants for end-stage
reflux nephropathy; in these patients urinary protein excretion
ranged from 1.2 to 5.8 g/day [21]. Senekjian et al, in a study of 5
patients followed for 3 to 9 years, found progressive, irrevers-
ible renal failure following surgical correction of VUR [22].
Surgery had been performed in these patients when renal
function was already compromised; initial creatinine clearances
were 23 to 53 mI/mm at the time of operation. The patients
remained normotensive, either spontaneously or on therapy,
and they were free of urinary tract infection, but all 5 developed
end-stage renal failure. Four of the 5 had substantial and
persistent proteinuria, and a biopsy specimen from one patient
showed focal glomerulosclerosis.
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In a comprehensive study of 54 patients with refiux nephrop-
athy, Torres et al assessed renal function, protein excretion,
and glomerular histology and found that the clinical progression
to end-stage renal disease was not appreciably altered by
surgical correction of reflux in its advanced stages [15]. In
addition, all of their patients with progressive renal disease had
significant proteinuria. The renal biopsy showed mesangial
hypercellularity and increased mesangial matrix; the patients
with proteinuria also had a prominent focal and segmental
glomerulosclerosis.
Dr. Belicza, Flier, and I recently performed a retrospective
clinicopathologic study of 51 patients whose kidneys were
removed surgically for chronic pyelonephritis associated with
VUR or obstruction (unpublished data). In the extensively
sampled kidneys from these patients, lesions of segmental and
focal glomerulosclerosis were found in 14 cases (28%). One-half
of those with focal glomerulosclerosis had radiologic or mor-
phologic evidence of bilateral renal disease and a serum creati-
nine of over 2.5 mgldl. Sixty-three percent had 24-hour urinary
protein excretions greater than 1 g/day, and 25% had excretions
greater than 3 glday. In contrast, with few exceptions, patients
without focal sclerosis had normal serum creatinine levels,
minimal proteinuria, and unilateral disease.
It is clear, therefore, that focal and segmental glomeruloscler-
osis develops in some patients with refiux nephropathy and
chronic pyelonephritis and that, particularly in patients with
bilateral disease, it is associated with significant proteinuria and
progressive renal damage. These findings suggest that the
glomerular lesion might be an important cause of deterioration
of renal function in patients with VUR, particularly when
neither hypertension, nor recurrent infection, nor obstruction
can explain the worsening of renal function.
Pat ho genesis of glomerulosclerosis and proteinuria
The mechanisms by which proteinuria and glomerulosciero-
sis develop in patients with reflux nephropathy are subjects of
current investigation. Whereas some of the protein excreted
may be "tubular" in origin [23], increased glomerular perme-
ability is the major cause of excessive protein loss: more than
60% of the protein excreted is albumin, and electron microsco-
py of glomeruli shows loss of foot processes and other visceral
epithelial changes characteristic of glomerular proteinuria.
Glomerular proteinuria was well documented in the patient
under discussion today. At least four mechanisms might be
involved in the genesis of these glomerular lesions: (1) immuno-
logic injury; (2) macromolecular trapping and mesangial dys-
function; (3) vascular alterations and hypertension; and (4)
glomerular hyperfiltration. I will discuss each of these, but I
favor the last one.
Immunologic injury. The presence of 1gM and C3 in the
sclerotic areas and mesangium of more than 50% of the patients
with focal sclerosis raises the possibility of an immune reaction.
The focal lesions could be caused by circulating or in-situ
deposited immune complexes in which the antigen is a bacterial
product or an autologous tubular antigen. It seems unlikely that
bacterial antigens are involved; glomeruli are remarkably free
of immune complexes in the acute and healing phases of acute
pyelonephritis [24, 25], and focal sclerosis usually develops
long after infection has disappeared. With the exception of a
simple electron microscopic demonstration in glomeruli of a
coiled structure and spherical particles thought to represent
altered bacterial forms [181, bacterial antigen has not been
localized in glomeruli of patients with chronic pyelonephritis
[26, 27].
Two possible autologous renal antigens are brush-border—
related antigen and Tamm-Horsfall protein. The former is an
unlikely candidate for an auto-antigen, because the lesion
associated with brush-border-antigen—induced glomerulone-
phritis is membranous nephropathy, not focal sclerosis. Tamm-
Horsfall protein, however, is a possible endogenous antigen.
This substance, a urinary glycoprotein localized largely to casts
and epithelial cells in the distal tubule [28], gains access to the
renal interstitium in both human [291 and experimental [30]
refiux nephropathy. Elevated titers of serum antibody to
Tamm-Horsfall protein are found in patients with acute pyelo-
nephritis and reflux nephropathy, although the levels appear to
be diminished in patients with chronic disease [31]. Because
macromolecules can move from the mesangium to the macula
densa of distal tubules [32], it is at least theoretically possible
that Tamm-Horsfall protein could gain access in a retrograde
fashion to the mesangium during obstruction or reflux, and
elicit a local immune-complex reaction. Thus far, however, we
and others have failed to localize Tamm-Horsfall protein in the
mesangium of these patients [21].
Macromolecular trapping and mesangial dysfunction. An
alternative explanation for the deposition of 1gM and C3 is that
macromolecules are trapped as a result of mesangial "dysfunc-
tion" [32, 33]. Although mesangial function and transport have
not been studied in VUR, Raij et al found that they deviated
from normal in rats with ureteral obstruction [34], These
authors found increased mesangial accumulation of radiola-
beled, aggregated IgG in obstructed kidneys; this accumulation
appeared to be caused by a blockade of the efferent limb, which
removes macromolecules from the mesangium.
If trapping leads to deposition of macromolecules in glomeru-
li, the reasons for predominant deposition of 1gM and C3 are not
clear. Velosa, Miller, and Michael found fixation of heterolo-
gous complement in hyalinizing glomeruli of kidneys with
chronic pyelonephritis as well as early components of comple-
ment and properdin; these findings suggest activation of both
classic and alternate complement pathways [35]. In view of the
marked biochemical heterogeneity of the mesangial matrix—it
contains laminin, fibronectin, collagen, and glycosaminogly-
cans—C3 and 1gM deposition might conceivably represent
interactions with components of the mesangial matrix and local
specific activation of the alternate complement pathway.
Vascular alterations and hypertension. Although many of the
reported patients with focal sclerosis and persistent proteinuria
were hypertensive, it is unlikely that hypertension is the cause
of focal sclerosis. Blood pressure often was only slightly
elevated, and proteinuria sometimes preceded the hyperten-
sion, the latter becoming manifest only after renal insufficiency
developed. In addition, focal glomeruloscierosis is not a promi-
nent histologic feature of essential hypertension.
Vascular changes consisting of intimal hyperplasia and medi-
al hypertrophy are present to some degree in the majority of
patients reported to have focal sclerosis and reflux nephrop-
athy, but these changes often exist in the absence of hyperten-
sion [15]. The pathogenesis of these vascular alterations is
unknown, and they might play a role in the development of
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glomerulosclerosis, The point is that although hypertension
clearly contributes to progressive renal failure in reflux
nephropathy, it is not the main cause of proteinuria associated
with focal sclerosis.
Glomerular hyperfiltration. The final explanation is that
proteinuria and glomerulosclerosis result from heniodynamic
changes occurring in glomeruli adapting to reductions in renal
mass. Proteinuria, glomeruloscierosis, and progressive azote-
mia develop regularly in rats when renal mass is reduced
approximately 75% either by surgical resection or infarction
[36, 37]. The rapidity with which glomerulosclerosis develops
and the extent of lesions are proportional to the degree of renal
ablation [38]. Recent micropuncture studies performed in rats
one week following ablation of 90% of renal mass showed an
approximately threefold increase of single-nephron glomerular
filtration rate in remnant glomeruli over control glomeruli; this
increase was associated with elevations of both capillary plas-
ma flow and mean glomerular transcapillary hydraulic pressure
difference [39]. At the same time, protein excretion by remnant
glomeruli was increased approximately twenty fold. Clearance
studies using dextrans and horseradish peroxidases with vary-
ing isoelectric points shnwed defects in both the size and
charge-selective properties of the glomerulus [38]. Morphologic
studies showed endothelial and epithelial alterations as well as
increased deposition of 1gM in the mesangium and in sclerotic
foci of remnant glomeruli [381. In addition, deposition of tracer
molecules (ferritin) in the mesangium was readily documented
[38].
The contribution of hemodynamic changes to glomerular
injury was shown in animals subjected to dietary protein
restriction prior to renal ablation, For reasons that are not clear,
protein restriction obviates the increase in single-nephron GFR,
capillary plasma flow, and transcapillary hydraulic pressure
that occurs after renal ablation. Animals treated in this way
manifested much less proteinuria, and the charge-selective
defect also was ameliorated; normal renal structure and perme-
ability to tracer molecules was maintained [39].
The basis for the adaptive hemodynamic alterations in this
model is still unclear, as is the precise sequence of events
leading to increased glomerular permeability, mesangial alter-
ations, and glomeruloscierosis. With few exceptions, however,
the clinical data presented earlier suggest that such a maladapt-
ive response might be the cause of glomerulosclerosis and
progressive renal damage in reflux nephropathy. As noted
earlier, most of the patients with proteinuria, reflux nephrop-
athy, and glomerulosclerosis had abnormal renal function or
developed it shortly after proteinuria was discovered. In our
series, daily protein excretion exceeding 1 g occurred mainly in
patients with bilateral disease and focal sclerosis. In the series
of Kincaid-Smith and Becker, only one of 14 patients with
unilateral VUR and reflux nephropathy had a protein excretion
greater than 0.2 g/day, whereas 18 of 37 patients with bilateral
reflux nephropathy had this degree of proteinuria [191. Al-
though glomerular lesions were present in patients with normal
renal function, the more advanced and widespread lesions
appeared in biopsies of patients with impaired renal function.
All the patients reported by Senekjian et al had creatinine
clearances less than 50% of normal [221, and Torres et al noted a
similar correlation [15].
The patient under discussion today had bilateral disease,
severe glomerular lesions, and abundant proteinuria. Although
his creatinine clearance was normal, the biopsy showed total or
partial sclerosis of two-thirds of his glomeruli. It is likely that
his existing hyperfiltering glomeruli have maintained a normal
GFR, but that progressive sclerosis of remaining glomeruli will
eventually lead to a reduction of GFR.
Does the progressive glomeruloscierosis induced by adaptive
changes in remnant nephrons also occur in other renal disor-
ders? Experimentally, focal glomerulosclerosis can be induced
or accelerated in animals given puromycin aminonucleoside
following unilateral nephrectomy [37]. In addition, evidence
suggests that diabetic glomerulosclerosis is accelerated in ex-
perimental diabetes following removal of one kidney [40]. In
humans, proteinuria, glomerulosclerosis, or both have been
reported as complications of analgesic-abuse nephropathy [41,
42], segmental hypoplasia (the Ask-Upmark kidney) [43], and
oligomeganephronia [44]. In the last condition, congenital renal
hypoplasia reduces the number of glomeruli by more than one-
half, but the remaining glomeruli undergo hypertrophy and the
glomerular filtration rate increases, Patients with this disease
develop renal insufficiency at an early age because of progres-
sive glomeruloscierosis. Finally, the presence of a single kidney
since childhood appears to predispose patients to the develop-
ment of focal sclerosis, In a recent review of 586 renal patholo-
gy specimens, Kiprov, Colvin, and McCluskey found unilateral
renal agenesis in 5 of 29 patients with focal glomerulosclerosis;
this incidence was greater than that anticipated by chance alone
(P < 0.0001) [45]. They also found focal glomerulosclerosis in 2
of 7 patients with unilateral renal agenesis (29%) among 9200
autopsies. By contrast, no glomerular disease was found in 10
patients who died 8 to 46 years after having unilateral nephrec-
tomy in adulthood,
Surgery for reflux
Is surgical correction of VUR indicated in this patient? The
value of surgical treatment of VUR in general is now under
close scrutiny. Normand and Smellie have presented the case
for conservative management with prophylactic antibacterial
therapy [461. They found no evidence that prognosis in children
is improved by ureteral implantation, particularly in children
older than age 5. Surgical correction of reflux probably does not
prevent new scar formation. Whether persistent reflux in the
absence of infection causes continuing renal damage is contro-
versial. The experimental [7, 8] and clinical [28, 47, 481 evi-
dence is conflicting. However, even those who believe that
"sterile reflux" is harmful acknowledge that renal damage
occurs principally in high-pressure urinary tract obstructjon.
These disorders, including posterior urethral valves and other
congenital obstructive lesions, lead to the "generalized or
diffuse" form of reflux nephropathy [49] rather than to the more
typical, focal coarse scarring. With regard to prevention of
progressive glomerulosclerosis, in the studies reported thus far,
surgery was performed for reflux after renal function already
had begun to decline. In such cases, progression of renal
insufficiency occurred despite surgical correction of the VUR.
In the series of Torres et al, the mean duration from the time of
diagnosis to the time end-stage renal failure developed was 79
13 months for 11 surgically treated patients versus 86 11
months for 16 untreated patients [15]. The patient under discus-
sion today presented a particularly difficult problem in manage-
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ment, because his renal function was normal when the protein-
uria was discovered. Perhaps we can consider the decision to
reimplant his ureters later in this discussion.
Questions and answers
DR. JEROME P. KASSIRER: Dr. Cotran, what is your hypothe-
sis to explain why only some patients with reflux nephropathy
develop the focal sclerotic lesion?
DR. COTRAN: The data suggest that most, but by no means
all, patients who develop the lesion are the ones who have
rather severe bilateral scarring. I suspect this is because it is
these patients' glomeruli that attain the hemodynamic alter-
ations sufficient to cause focal sclerosis. Once focal sclerosis
starts in some glomeruli, the lesions become progressive for the
reasons discussed earlier. Hypertension is another poor prog-
nostic sign in these patients.
DR. KASSIRER: Do you have any advice for clinicians who
follow patients with reflux? How can they prevent the lesions
from developing?
DR. COTRAN: The most important things are preventing initial
scarring by treating infection early, and preventing further
reductions in kidney function by treating hypertension.
DR. KASSIRER: Do individuals who have had a kidney re-
moved and live for many years thereafter eventually develop
focal sclerosis?
DR. COTRAN: As I stated earlier, Kiprov, Colvin, and
McCluskey examined 9200 consecutive autopsies at the Massa-
chusetts General Hospital and found 10 adults who had under-
gone remote nephrectomy. None of these developed focal
sclerosis. The data from transplant registries show no evidence
that kidney donors fare worse than the control population. Dr.
Kiprov is here—he might have additional comments.
DR. D0BRI KIPR0v (Department of linmunopathology, Mas-
sachusetts General Hospital, Boston, Mass.): The available
data are insufficient to prove that patients with adult unilateral
nephrectomy do not develop focal sclerosis. However, none of
our 10 patients with adult unilateral nephrectomy developed
any glomerular disease. These patients had lived with a single
kidney between 8 and 46 years.
DR. VIVIAN PINN (Assistant Professor of Pathology, Tufts
University School of Medicine): As you know, most patients
with chronic pyelonephritis have considerable damage to the
interstitium and the tubules secondary to bacterial infection and
ischemic changes with peritubular capillary disruption. How
much of the progressive renal damage do you think can be
attributed to this progressive lesion and how much to the
glomeruloscierosis?
DR. COTRAN: Most of the evidence suggests that following
the initial few episodes of bacterial pyelonephritis, which cause
renal scarring, progressive renal disease leading to end-stage
renal failure is not usually caused by persistent or recurrent
renal infection. There is little evidence that persistent renal
infection per se causes these kidneys to continue to deteriorate.
In end-stage chronic pyelonephritis or reflux nephropathy,
100% of the kidneys have some glomerular scarring—either
total hyalinization, focal sclerosis, or both. This issue was well
studied by Bhathena et al [21]. Progression in chronic pyelone-
phritis appears to result from hypertension, focal glomerulo-
sclerosis, or both. Some patients, of course, also have obstruc-
tion or stones. I think this scenario explains patients who in the
past were thought to have so-called abacterial" chronic pyelo-
nephritis.
DR. JOHN T. HARRINGTON: In the piglets with concave and
convex papillae, has anyone shown whether concave papillae
change with development, or do they always remain concave?
DR. COTRAN: In piglets I am not sure, but in humans
Tamminen and Kaprio found no difference in the distribution of
these types of papillae in kidneys of premature, young infants or
children up to age 9.8 years [50]. From the other side of the
coin, both Hodson and Ransley and Risdon agree that simple
nonrefluxing papillae may become refluxing from prolonged
obstruction or adjacent inflammation. This explains the few
repeated instances of new scars developing in already scarred
kidneys. But this does not happen very frequently.
DR. HARRINOTON: If one transplants an isogeneic kidney into
an animal that has had a five-sixths nephrectomy, does the
lesion in the remnant kidney reverse?
DR. COTRAN: People are looking at this question now in an
attempt to discover the mechanism of the hemodynamic
changes.
DR. CECIL H. COGGINS (Renal Unit, Massachusetts General
Hospital, Boston, Mass.): Do you think this pathogenesis
applies to other forms of focal sclerosis as well?
DR. COTRAN: As I said earlier, patients with other forms of
reduction in renal mass also develop focal sclerosis, but this is,
of course, indirect evidence. There are some people who
believe—Brenner and colleagues being the main proponents—
that examples of progressive sclerosis may be due to hyperfil-
tration [51]. There is, as you know, evidence for hyperfiltration
in diabetes [52]. We recently examined the kidneys from a
patient who had diabetes and unilateral renal artery stenosis;
the kidney with renal artery stenosis had much less diabetic
glomeruloscierosis. There is a similar case in the literature with
a unilateral Kimmelstiel-Wilson lesion [53].
DR. KASSIRER: Dr. Steinman, maybe you could elaborate on
the rationale for correcting the reflux surgically in the patient
discussed today. The evidence sounds unconvincing that such
treatment is likely to be beneficial.
DR. THEODORE STEINMAN (Director, Dialysis Unit, Beth
Israel Hospital, Boston, Mass.): The best defense of our
decision to operate on the patient in question is that he had
normal renal function but substantial proteinuria. While it is not
known whether correcting influx in individuals with normal
renal function will protect against loss of kidney function over
the course of years, it is well documented that correction of
reflux in individuals who already have moderate to severe
impairment of renal function does not prevent the inexorable
course to end-stage renal disease. An intravenous pyelogram,
performed one week after correction of the reflux, revealed the
persistence of significant reflux and of pelvocalyceal dilation
with a large postvoid residual. In contrast, a repeat study
performed 13 months later revealed a diminution in the pelvoca-
lyceal dilation, a return of the ureters to normal caliber, and
marked improvement in the postvoid residual. Significant corti-
cal scarring, noted on his original films, was not changed over
the initial 13 months of observation. More importantly, his
kidney function continued to be normal 13 months later, but
heavy proteinuria persisted (2.5 g/24 hours). Most patients with
similar degrees of proteinuria and severity of focal sclerosis do
progress to renal failure, albeit over a long time. A much longer
Nephrology Forum 533
followup is necessary therefore before any statement can be
made whether correction of the reflux was an appropriate
procedure for this patient and is indicated in other similar
patients. We plan to repeat his kidney biopsy in the future and
compare the results with the original pathologic study.
DR. KASSIRER: Of course, if he does not develop focal
sclerosis you will never know whether he might not have
developed it without reimplantation. Clearly, you have im-
proved his reflux but I doubt that you will be able to draw any
conclusions about subsequent glomerular disease.
DR. ANDREW LEVEY (Renal Division, NEMC): Another
example of glomerular changes in interstitial disease is the
occasional appearance of heavy proteinuria and nephrotic syn-
drome in patients with allergic interstitial nephritis following
treatment with nonsteroidal antiinflammatory agents [54, 55].
Does your hypothesis explain the glomerular lesions in these
patients?
DR. COTRAN: I don't think so. This association has been
reported also with drugs other than nonsteroidal antiinflamma-
tory agents, for example, ampicillin [56]. Most of these patients
have a low GFR. The renal lesion is one of minimal change
disease with extensive loss of foot processes, and I don't
remember any of the patients having focal sclerosis. I think that
the association in these cases may be due to the fact that both
minimal change disease and acute interstitial nephritis are
immune-mediated in some way, but this is only speculation.
DR. HARRINGTON: In patients with interstitial nephritis due
to nonsteroidal antiinflammatory agents, although the overall
GFR is reduced, you could still argue that single-nephron GFR
might be increased. Are there any experimental models of
interstitial nephritis secondary to nonsteroidal antiinflamma-
tory agents in which one could test that hypothesis?
DR. COTRAN: To my knowledge there is no good model for
acute drug-induced interstitial nephritis.
DR. STEINMAN: It is known that patients with the idiopathic
nephrotic syndrome who have a pathologic picture of focal
sclerosis will have the initial lesion seen in the juxtamedullary
glomeruli. Are the juxtamedullary glomeruli the first areas of
involvement in patients who have focal sclerosis as a conse-
quence of reflux nephropathy?
DR. C0TRAN: We could not detect a predominant juxtaglo-
merular involvement in our study.
DR. NICOLAOS MADIAS (Renal Division, NEMC): You men-
tioned that rats with a remnant kidney on low-protein diets do
not develop an increase in single-nephron GFR and proteinuria.
What happens to them in terms of survival?
DR. COTRAN: Others have shown long-term improved renal
function and survival in similar models with low-protein diets
[57].
DR. SERAFINO GARELLA (Division of Renal Diseases, Rhode
Island Hospital, Providence, Rhode Island): According to the
concepts you have expressed, the development of sclerosis
seems related not to the hemodynamic changes found in experi-
mental models and patients with reflux nephropathy, but rather
to the secondary development of increased glomerular perme-
ability per Se. Are you postulating that the alteration might be
due to some unidentified material that is filtered into the
mesangium and that results ultimately in sclerosis? If that were
true, what would prevent patients with lipoid nephrosis, who
have increased glomerular permeability but no concurrent
hemodynamic changes, from developing the same lesion? This
ought to occur, unless one postulates that the patients with
lipoid nephrosis happen not to filter some compound that
patients with refiux nephropathy or partially nephrectomized
animals do.
DR. COTRAN: Patients with lipoid nephrosis may or may not
have some hyperfiltration, but they have a lot of proteinuria.
Most of the protein leaks into Bowman's space. My guess—and
this is only speculation—is that in human lipoid nephrosis there
is diffusely leaky capillary wall without much necrosis of
endothelial or epithelial cells. The "selective" protein lost from
the circulation ends up in the urinary space and very little
accumulates in the mesangium. In conditions that lead to focal
sclerosis, such as hyperfiltration or hyperfiltration superim-
posed on an increased permeability (as occurs in the aminonu-
cleoside model with unilateral nephrectomy), there is also
cellular injury, and some larger proteins (including fibrin-
related proteins) accumulate in the mesangium [331.The precise
mechanism by which this leads to progressive sclerosis is
unknown but is now being studied in a number of laboratories
[32].
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